Outi Paija

723 total citations
9 papers, 509 citations indexed

About

Outi Paija is a scholar working on Oncology, Genetics and Orthopedics and Sports Medicine. According to data from OpenAlex, Outi Paija has authored 9 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Genetics and 2 papers in Orthopedics and Sports Medicine. Recurrent topics in Outi Paija's work include Bone health and treatments (4 papers), Cancer Treatment and Pharmacology (4 papers) and Estrogen and related hormone effects (3 papers). Outi Paija is often cited by papers focused on Bone health and treatments (4 papers), Cancer Treatment and Pharmacology (4 papers) and Estrogen and related hormone effects (3 papers). Outi Paija collaborates with scholars based in Finland, Spain and Netherlands. Outi Paija's co-authors include H.P. Sleeboom, Antonio Frassoldati, Patrick Neven, Antonio Llombart‐Cussac, Gϋnter von Minckwitz, Richard de Boer, Robert E. Coleman, Carlos H. Barrios, Nigel Bundred and N. Davidson and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and The Breast.

In The Last Decade

Outi Paija

9 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Outi Paija Finland 6 443 151 149 98 93 9 509
Hiroshi Kaise Japan 12 228 0.5× 44 0.3× 33 0.2× 183 1.9× 60 0.6× 44 420
Alberto Dalla Volta Italy 10 102 0.2× 28 0.2× 69 0.5× 94 1.0× 93 1.0× 37 321
Viktor Wette Austria 9 406 0.9× 38 0.3× 54 0.4× 288 2.9× 114 1.2× 12 540
Ferdinand Haslbauer Austria 8 211 0.5× 38 0.3× 51 0.3× 53 0.5× 79 0.8× 26 292
A. Nielsen Denmark 12 64 0.1× 22 0.1× 86 0.6× 41 0.4× 60 0.6× 28 328
Nilesh Mehta United States 5 319 0.7× 50 0.3× 71 0.5× 27 0.3× 100 1.1× 6 389
Francesca Valcamonico Italy 10 126 0.3× 27 0.2× 19 0.1× 63 0.6× 122 1.3× 43 317
Karin Weijers Netherlands 7 118 0.3× 45 0.3× 10 0.1× 46 0.5× 47 0.5× 9 399
Chenglin Yang China 12 122 0.3× 48 0.3× 34 0.2× 59 0.6× 264 2.8× 26 431
Robbin Blau United States 6 403 0.9× 88 0.6× 11 0.1× 169 1.7× 156 1.7× 7 492

Countries citing papers authored by Outi Paija

Since Specialization
Citations

This map shows the geographic impact of Outi Paija's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Outi Paija with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Outi Paija more than expected).

Fields of papers citing papers by Outi Paija

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Outi Paija. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Outi Paija. The network helps show where Outi Paija may publish in the future.

Co-authorship network of co-authors of Outi Paija

This figure shows the co-authorship network connecting the top 25 collaborators of Outi Paija. A scholar is included among the top collaborators of Outi Paija based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Outi Paija. Outi Paija is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Coleman, Robert E., Richard de Boer, Holger Eidtmann, et al.. (2012). Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results. Annals of Oncology. 24(2). 398–405. 258 indexed citations
2.
Vihinen, Pia, Outi Paija, Atte Kivisaari, Leena Koulu, & Heikki Aho. (2011). Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report. Journal of Medical Case Reports. 5(1). 243–243. 14 indexed citations
3.
Llombart‐Cussac, Antonio, Antonio Frassoldati, Outi Paija, et al.. (2011). Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial. Clinical Breast Cancer. 12(1). 40–48. 108 indexed citations
4.
Joensuu, Heikki, Pirkko‐Liisa Kellokumpu‐Lehtinen, Riikka Huovinen, et al.. (2011). Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial. Journal of Clinical Oncology. 30(1). 11–18. 76 indexed citations
5.
6.
Paija, Outi, Kari Laine, Mika Leinonen, et al.. (2005). Entacapone Increases Levodopa Exposure and Reduces Plasma Levodopa Variability When Used With Sinemet CR. Clinical Neuropharmacology. 28(3). 115–119. 22 indexed citations
7.
8.
Kailajärvi, Marita, Eeva Salminen, Outi Paija, et al.. (2004). Serum bone markers in breast cancer patients during 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy.. PubMed. 24(2C). 1271–4. 21 indexed citations
9.
Huupponen, Risto, et al.. (2003). Pharmacokinetics of Deramciclane, a???Novel Anxiolytic Agent, after Intravenous and Oral Administration. Drugs in R&D. 4(6). 339–345. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroshi Kaise Breakdown of academic impact, for papers by Alberto Dalla Volta Breakdown of academic impact, for papers by Viktor Wette Breakdown of academic impact, for papers by Ferdinand Haslbauer Breakdown of academic impact, for papers by A. Nielsen Breakdown of academic impact, for papers by Nilesh Mehta Breakdown of academic impact, for papers by Francesca Valcamonico Breakdown of academic impact, for papers by Karin Weijers Breakdown of academic impact, for papers by Chenglin Yang Breakdown of academic impact, for papers by Robbin Blau
Rankless by CCL
2026